All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Ongoing | 2004-001825-69 | A Multi Center, Open label, Extension study of RA 1 using Extracoproreal photoimmune therapy with Uvadex | not-yet-due | |
| Not reported | 2004-002693-37 | A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEX IN THE TREATMENT OF PATIENTS WITH MODERATELY ACTIVE CROHN’S DISEASE WHO ARE REFRACTORY OR INTOLERANT TO IMMUNOSUPPRES... | 2006-09-13 | due-trials |
| Not reported | 2004-003774-29 | A Randomized, Controlled, Parallel-Group, Multicenter Study of Extracorporeal Photoimmune Therapy with THERAKOS* UVADEX* for the Treatment of Patients with Newly Diagnosed Acute Graft-versus-Host Dise... | 2007-09-04 | due-trials |
| Reported results | 2010-022780-35 | A Randomized Controlled Study of Extracorporeal Photopheresis (ECP) Therapy with UVADEX TM for the Treatment of Patients with Moderate to Severe Chronic Graft-versus-Host Disease (cGvHD). Estudio c... | 2017-03-19 | due-trials |
| Reported results | 2014-004806-14 | Single-Arm Study to Assess the Efficacy of UVADEX® (methoxsalen) Sterile Solution in Conjunction with the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients with Steroid-Refractory Acute Gra... | 2019-07-16 | due-trials |